ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
3.590
-0.260 (-6.75%)
Mar 4, 2026, 2:45 PM EST - Market open
ENDRA Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+735.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $38 → $30 | Strong Buy | Maintains | $38 → $30 | +735.65% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +958.50% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +1,181.34% | May 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $75 → $50 | Strong Buy | Maintains | $75 → $50 | +1,292.76% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +389,872.14% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $175,000 → $15,750 | Strong Buy | Reiterates | $175,000 → $15,750 | +438,618.66% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $210,000 → $175,000 | Strong Buy | Maintains | $210,000 → $175,000 | +4,874,551.81% | Apr 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $210,000 | Strong Buy | Initiates | $210,000 | +5,849,482.17% | Jul 15, 2019 |